Literature DB >> 6337953

Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis.

F H Derkx, L Tan-Tjiong, G J Wenting, F Boomsma, A J Man in 't Veld, M A Schalekamp.   

Abstract

An assay of plasma prorenin was developed in which the conversion to renin occurred under apparently optimal conditions. Some characteristics of the assay were 1) prorenin was activated by Sepharose-bound trypsin at 4 degrees C; 2) the concentration of activator was not critical provided that incubation was prolonged until renin activity had reached a plateau; and 3) this plateau was stable and had the same height as after maximal activation with acid, pepsin, plasmin or urokinase. Maximal activity with Sepharose-bound trypsin at 4 degrees C was higher than with cryoactivation, and optimal conditions were more readily reproduced than with trypsin at 37 degrees C or with acid-activation. The assay was used for measurements in peripheral and renal vein plasma after captopril in hypertensive patients with unilateral renal artery stenosis. Peripheral renin rose within 30 minutes after a first dose of captopril, 50 mg orally, and it remained high with chronic treatment. In contrast, peripheral prorenin fell initially and rose after 4 hours. These changes in peripheral plasma were related to changes in the secretion rates of the two forms of renin from the affected kidney. Thus chronic, but not acute, stimulation of renin release was associated with an increased secretion rate of prorenin. The late rise in prorenin is probably an indication of enhanced synthesis in the kidney, so that more prorenin is available for conversion. The data suggest that prorenin is indeed a biosynthetic precursor of renin and that, at least under certain circumstances, a major proportion of circulating prorenin originates from the kidney.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337953     DOI: 10.1161/01.hyp.5.2.244

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  High plasma prorenin in non diabetic siblings of non insulin-dependent diabetes mellitus patients.

Authors:  N Glorioso; C Troffa; G Tonolo; F Filigheddu; F Dettori; M Ciccarese; A Saller; A Soro; E Brocco; P Pinna-Parpaglia; F Mantero; P P Faronato; R Nosadini; M Maioli
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

2.  Liver X receptors alpha and beta regulate renin expression in vivo.

Authors:  Fulvio Morello; Rudolf A de Boer; Knut R Steffensen; Massimiliano Gnecchi; Jeffrey W Chisholm; Frans Boomsma; Leonard M Anderson; Richard M Lawn; Jan-Ake Gustafsson; Marco Lopez-Ilasaca; Richard E Pratt; Victor J Dzau
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

3.  Cyclical secretion of prorenin during the menstrual cycle: synchronization with luteinizing hormone and progesterone.

Authors:  J E Sealey; S A Atlas; N Glorioso; H Manapat; J H Laragh
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

4.  Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension.

Authors:  A H van den Meiracker; P J Admiraal; A J Man in 't Veld; F H Derkx; H J Ritsema van Eck; P Mulder; P van Brummelen; M A Schalekamp
Journal:  BMJ       Date:  1990-07-28

5.  Raised plasma renin and prorenin in rheumatoid vasculitis.

Authors:  M Boers; F C Breedveld; B A Dijkmans; P C Chang; P van Brummelen; F H Derkx; A Cats
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

6.  Splint renal function after captopril in unilateral renal artery stenosis.

Authors:  G J Wenting; H L Tan-Tjiong; F H Derkx; J H de Bruyn; A J Man in't Veld; M A Schalekamp
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-24

7.  Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan.

Authors:  Liffert Vogt; Femke Waanders; Frans Boomsma; Dick de Zeeuw; Gerjan Navis
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

8.  Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels.

Authors:  Christina M Gant; Gozewijn D Laverman; Liffert Vogt; Maartje C J Slagman; Hiddo J L Heerspink; Femke Waanders; Marc H Hemmelder; Gerjan Navis
Journal:  BMC Nephrol       Date:  2017-12-20       Impact factor: 2.388

9.  Very preterm birth is a risk factor for increased systolic blood pressure at a young adult age.

Authors:  Mandy G Keijzer-Veen; Arzu Dülger; Friedo W Dekker; Jeroen Nauta; Bert J van der Heijden
Journal:  Pediatr Nephrol       Date:  2009-12-15       Impact factor: 3.714

10.  Functional tests to guide management in an adult with loss of function of type-1 angiotensin II receptor.

Authors:  Daan H H M Viering; Anneke P Bech; Jeroen H F de Baaij; Eric J Steenbergen; A H Jan Danser; Jack F M Wetzels; René J M Bindels; Jaap Deinum
Journal:  Pediatr Nephrol       Date:  2021-03-25       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.